![](/img/cover-not-exists.png)
470P Progression-free survival and response rate with EGFR tyrosine kinase inhibitor treatment according to EGFR mutation subtype in advanced lung adenocarcinoma
Chai, C.S., Liam, C.K., Pang, Y.K., Kow, K.S., Wong, C.K., Poh, M.E., Tan, J.L.Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw594.034
Date:
December, 2016
File:
PDF, 85 KB
english, 2016